No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Belgian biopharmaceutical company UCB and American pharmaceutical giant Eli Lilly have led a US$52 million funding round for RNA biotech startup Switch Therapeutics for its conditionally activated siRNA…
Read More
UNITED KINGDOM –AstraZeneca’s Alexion will pay US$775 million to Roche’s subsidiary, Chugai Pharmaceutical to resolve all patent disputes related to the C5 inhibitor Ultomiris (ravulizumab), the two companies have said.…
Read More
BELGIUM – BrightInsight, the leading global platform for biopharma and medtech regulated digital health solutions, has announced a collaboration with global biopharma, UCB, to develop digital care solutions for rare…
Read More
BELGIUM – UCB has completed the previously announced acquisition of international biopharmaceutical firm Zogenix for up to US$1.9 billion (€1.7 billion). UCB signed a definitive agreement in January to acquire…
Read More